Mike Ouimette

Insider Reports History

Entity
Individual
Location
C/O Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco, CA
Signature
/s/ Mike Ouimette
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mike Ouimette:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. General Counsel & Corp. Sec'y Common Stock 94K $1.09M $11.56 Jul 10, 2024 Direct
PLIANT THERAPEUTICS, INC. General Counsel & Corp. Sec'y Stock Option (Right to Buy) 63K Jan 23, 2024 Direct

Insider Reports Filed by Mike Ouimette

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLRX PLIANT THERAPEUTICS, INC. Jul 10, 2024 1 -$88.5K 4 Jul 12, 2024 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jul 9, 2024 1 $0 4 Jul 11, 2024 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jan 23, 2024 2 $0 4 Jan 24, 2024 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jan 17, 2024 1 -$89.5K 4 Jan 19, 2024 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jul 20, 2023 1 -$83.5K 4 Jul 21, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jul 17, 2023 1 -$230K 4 Jul 19, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jul 14, 2023 1 $0 4 Jul 18, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Mar 30, 2023 3 -$206K 4 Apr 3, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Mar 29, 2023 1 $0 4 Mar 31, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jan 25, 2023 2 $0 4 Jan 27, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jan 23, 2023 5 -$322K 4 Jan 25, 2023 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Dec 22, 2022 1 -$56.7K 4 Dec 23, 2022 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Dec 19, 2022 2 -$90.1K 4 Dec 21, 2022 General Counsel & Corp. Sec'y
PLRX PLIANT THERAPEUTICS, INC. Jan 26, 2022 1 $0 4 Feb 2, 2022 General Counsel & Corp. Sec'y